Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Performance estimation of three-phase induction motors from no-load startup test without speed acquisition.

Pereira LA, Perin M, Pereira LFA, Ruthes JR, de Sousa FLM, de Oliveira ECP.

ISA Trans. 2019 Jun 6. pii: S0019-0578(19)30260-5. doi: 10.1016/j.isatra.2019.05.028. [Epub ahead of print]

PMID:
31208884
2.

Induction distribution of five-phase induction machines under open-phase fault.

Pereira LA, Nicol G, Pereira LFA, Perin M.

ISA Trans. 2019 Jun 6. pii: S0019-0578(19)30262-9. doi: 10.1016/j.isatra.2019.06.001. [Epub ahead of print]

PMID:
31204056
3.

What methods have been used to estimate salt intake? A systematic review.

Perin MS, Gallani MCBJ, Andrechuk CRS, São-João TM, Rhéaume C, Cornélio ME.

Int J Food Sci Nutr. 2019 May 31:1-14. doi: 10.1080/09637486.2019.1620185. [Epub ahead of print]

PMID:
31148496
4.

Dietary sources of salt intake in adults and older people: a population-based study in a Brazilian town.

Perin MS, Cornélio ME, Oliveira HC, São-João TM, Rhéaume C, Gallani MBJ.

Public Health Nutr. 2019 Jun;22(8):1388-1397. doi: 10.1017/S1368980018003233. Epub 2018 Nov 26.

PMID:
30472972
5.

Safety and Effectiveness of Suture-mediated Arterial Closure Device in Hepatocellular Carcinoma Patients Who Underwent Drug-Eluting Beads Transarterial Chemoembolization.

De Fina B, Nasser F, Cavalcante RN, Campos CA, Galastri FL, Affonso BB, Wolosker N, Perin MA.

Ann Vasc Surg. 2019 Feb;55:203-209. doi: 10.1016/j.avsg.2018.05.077. Epub 2018 Sep 11.

PMID:
30217703
6.

Treating neuromyelitis optica with azathioprine: 20-year clinical practice.

Bichuetti DB, Perin MMM, Souza NA, Oliveira EML.

Mult Scler. 2019 Jul;25(8):1150-1161. doi: 10.1177/1352458518776584. Epub 2018 May 15.

PMID:
29761736
7.

Impact of Acute Kidney Injury on Short- and Long-term Outcomes After Transcatheter Aortic Valve Implantation.

Nunes Filho ACB, Katz M, Campos CM, Carvalho LA, Siqueira DA, Tumelero RT, Portella ALF, Esteves V, Perin MA, Sarmento-Leite R, Lemos Neto PA, Tarasoutchi F, Bezerra HG, de Brito FS Jr.

Rev Esp Cardiol (Engl Ed). 2019 Jan;72(1):21-29. doi: 10.1016/j.rec.2017.11.024. Epub 2018 Jan 19. English, Spanish.

PMID:
29358043
8.

Humoral immune response to measles and varicella vaccination in former very low birth weight preterm infants.

Ferreira CSM, Perin MCAA, Moraes-Pinto MI, Simão-Gurge RM, Goulart AL, Weckx LY, Dos Santos AMN.

Braz J Infect Dis. 2018 Jan - Feb;22(1):41-46. doi: 10.1016/j.bjid.2017.12.001. Epub 2018 Jan 5.

9.

Permanent Pacing After Transcatheter Aortic Valve Implantation: Incidence, Predictors and Evolution of Left Ventricular Function.

Monteiro C, Ferrari ADL, Caramori PRA, Carvalho LAF, Siqueira DAA, Thiago LEKS, Perin M, Lima VC, Guérios E, Brito Junior FS.

Arq Bras Cardiol. 2017 Dec;109(6):550-559. doi: 10.5935/abc.20170170. Epub 2017 Nov 27. English, Portuguese.

10.

Balloon Cryoablation for the Treatment of Paroxysmal Atrial Fibrillation.

Fenelon G, Scuotto F, Fischer C, Perin MA, Makdisse M, Paola AAV.

Arq Bras Cardiol. 2017 Sep;109(3):266-269. doi: 10.5935/abc.20170108. English, Portuguese. No abstract available.

11.

Myocardial Deformation by Echocardiogram after Transcatheter Aortic Valve Implantation.

Stangenhaus C, Vieira MLC, Fischer CH, Nunes ACB Filho, Perin MA, Caixeta AM.

Arq Bras Cardiol. 2017 May;108(5):480-483. doi: 10.5935/abc.20170013. English, Portuguese. No abstract available.

12.

Global Challenges and Solutions: Role of Telemedicine in ST-Elevation Myocardial Infarction Interventions.

Mehta S, Botelho R, Cade J, Perin M, Bojanini F, Coral J, Parra D, Ferré A, Castillo M, Yépez P.

Interv Cardiol Clin. 2016 Oct;5(4):569-581. doi: 10.1016/j.iccl.2016.06.013. Epub 2016 Aug 16. Review.

PMID:
28582005
13.

Assessment of long-term mortality in patients with complex coronary artery disease undergoing percutaneous intervention: comparison of multiple anatomical and clinical prognostic risk scores.

Janella BL, Campos CM, Caixeta A, Almeida BO, Brito FS Jr, Abizaid A, Perin MA.

EuroIntervention. 2017 Nov 20;13(10):1177-1184. doi: 10.4244/EIJ-D-16-00659.

14.

One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials.

de Ribamar Costa J Jr, Abizaid A, Bartorelli AL, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys PW.

EuroIntervention. 2016 Nov 20;12(10):1255-1262. doi: 10.4244/EIJV12I10A206.

15.

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry.

Tateishi H, Campos CM, Abdelghani M, Leite RS, Mangione JA, Bary L, Soliman OI, Spitzer E, Perin MA, Onuma Y, Serruys PW, Lemos PA, Brito FS Jr.

EuroIntervention. 2016 Mar;11(12):1409-18. doi: 10.4244/EIJV11I12A271.

16.

Pregnancy-associated spontaneous coronary artery dissection: insights from a case series of 13 patients.

Cade JR, Szarf G, de Siqueira ME, Chaves Á, Andréa JC, Figueira HR, Gomes MM Jr, Freitas BP, Filgueiras Medeiros J, Dos Santos MR, Fiorotto WB, Daige A, Gonçalves R, Cantarelli M, Alves CM, Echenique L, de Brito FS Jr, Perin MA, Born D, Hecht H, Caixeta A.

Eur Heart J Cardiovasc Imaging. 2017 Jan;18(1):54-61. doi: 10.1093/ehjci/jew021. Epub 2016 Feb 28.

PMID:
26928981
17.

Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.

Ribeiro HB, Nombela-Franco L, Muñoz-García AJ, Lemos PA, Amat-Santos I, Serra V, de Brito FS Jr, Abizaid A, Sarmento-Leite R, Puri R, Cheema AN, Ruel M, Nietlispach F, Maisano F, Moris C, Del Valle R, Urena M, Abdul Jawad Altisent O, Del Trigo M, Campelo-Parada F, Jimenez Quevedo P, Alonso-Briales JH, Gutiérrez H, García Del Blanco B, Perin MA, Siqueira D, Bernardi G, Dumont É, Côté M, Pibarot P, Rodés-Cabau J.

J Am Coll Cardiol. 2015 Nov 10;66(19):2075-2088. doi: 10.1016/j.jacc.2015.08.881.

18.

Metallic Limus-Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra-Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial.

Lemos PA, Abizaid AA, Meireles GC, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado AD, Mariani J Jr, Perin MA, Costantini C, Costa RA, Costa JR, Chamie D, Campos CA, Ribeiro E.

Cardiovasc Ther. 2015 Dec;33(6):367-71. doi: 10.1111/1755-5922.12159.

PMID:
26352896
19.

Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial.

Oliveira MD, Ribeiro EE, Campos CM, Ribeiro HB, Faillace BL, Lopes AC, Esper RB, Meirelles GX, Perin MA, Abizaid A, Lemos PA.

Cardiovasc Diagn Ther. 2015 Aug;5(4):264-70. doi: 10.3978/j.issn.2223-3652.2015.07.05.

20.

Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold.

De Ribamar Costa J Jr, Abizaid A, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Perin M, Seth A, Botelho R, Serruys PW; ABSORB EXTEND Investigators.

EuroIntervention. 2015 Jun;11(2):141-8. doi: 10.4244/EIJY15M05_06.

21.

Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death.

Urena M, Webb JG, Eltchaninoff H, Muñoz-García AJ, Bouleti C, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Lemos PA, Abizaid A, Sarmento-Leite R, Ribeiro HB, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Himbert D, Vahanian A, Immè S, Garcia E, Maisano F, del Valle R, Benitez LM, García del Blanco B, Gutiérrez H, Perin MA, Siqueira D, Bernardi G, Philippon F, Rodés-Cabau J.

J Am Coll Cardiol. 2015 Feb 10;65(5):437-48. doi: 10.1016/j.jacc.2014.11.027.

22.

Very late outcomes of drug-eluting stents coated with biodegradable polymers: insights from the 5-year follow-up of the randomized PAINT trial.

Marchini JF, Gomes WF, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Lemos PA.

Cardiovasc Diagn Ther. 2014 Dec;4(6):480-6. doi: 10.3978/j.issn.2223-3652.2014.12.05.

23.

Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial.

Mariani J Jr, Guedes C, Soares P, Zalc S, Campos CM, Lopes AC, Spadaro AG, Perin MA, Filho AE, Takimura CK, Ribeiro E, Kalil-Filho R, Edelman ER, Serruys PW, Lemos PA.

JACC Cardiovasc Interv. 2014 Nov;7(11):1287-93. doi: 10.1016/j.jcin.2014.05.024. Epub 2014 Oct 15.

24.

Early saphenous vein graft in-stent neoatherosclerosis by optical coherence tomography.

Ybarra LF, Weisz G, Rached FH, Perin MA, Caixeta A.

Can J Cardiol. 2014 Nov;30(11):1462.e15-6. doi: 10.1016/j.cjca.2014.06.004. Epub 2014 Jun 13. No abstract available.

PMID:
25249500
25.

Diurnal inhibition of NMDA-EPSCs at rat hippocampal mossy fibre synapses through orexin-2 receptors.

Perin M, Longordo F, Massonnet C, Welker E, Lüthi A.

J Physiol. 2014 Oct 1;592(19):4277-95. doi: 10.1113/jphysiol.2014.272757. Epub 2014 Aug 1.

26.

[Which follow-up of the second generation antipsychotic in adolescents?].

Huber-Gieseke T, Perin M, Narring F.

Rev Med Suisse. 2014 Jun 11;10(434):1302, 1304-7. Review. French.

PMID:
25073303
27.

Immobility reaction at birth in newborn infant.

Rousseau PV, Francotte J, Fabbricatore M, Frischen C, Duchateau D, Perin M, Gauthier JM, Lahaye W.

Infant Behav Dev. 2014 Aug;37(3):380-6. doi: 10.1016/j.infbeh.2014.05.001. Epub 2014 Jun 9.

PMID:
24922114
28.

First-in-man randomised comparison of a novel sirolimus-eluting stent with abluminal biodegradable polymer and thin-strut cobalt-chromium alloy: INSPIRON-I trial.

Ribeiro EE, Campos CM, Ribeiro HB, Lopes AC, Esper RB, Meirelles GX, Perin MA, Abizaid A, Lemos PA.

EuroIntervention. 2014;9(12):1380-4. doi: 10.4244/EIJV9I12A234.

29.

Coronary obstruction following transcatheter aortic valve implantation.

Ribeiro HB, Sarmento-Leite R, Siqueira DA, Carvalho LA, Mangione JA, Rodés-Cabau J, Perin MA, Brito FS Jr.

Arq Bras Cardiol. 2014 Jan;102(1):93-6. doi: 10.5935/abc.20130252. English, Portuguese.

30.

Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis.

de Brito FS Jr, Caixeta AM, Vieira ML, Nomura C, Figueiredo GL, Perin M, Marin-Neto JA.

EuroIntervention. 2015 Mar;10(11):1367. doi: 10.4244/EIJV10I11A233. No abstract available.

31.

In-stent neoatherosclerosis 10 years after bare metal stent implantation: ruptured vulnerable plaque by optical coherence tomography.

Caixeta A, Abizaid A, Brito F Jr, Almeida B, Perin M.

EuroIntervention. 2014 Aug;10(4):494. doi: 10.4244/EIJV10I4A83. No abstract available.

32.

Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.

Feres F, Costa RA, Abizaid A, Leon MB, Marin-Neto JA, Botelho RV, King SB 3rd, Negoita M, Liu M, de Paula JE, Mangione JA, Meireles GX, Castello HJ Jr, Nicolela EL Jr, Perin MA, Devito FS, Labrunie A, Salvadori D Jr, Gusmão M, Staico R, Costa JR Jr, de Castro JP, Abizaid AS, Bhatt DL; OPTIMIZE Trial Investigators.

JAMA. 2013 Dec 18;310(23):2510-22. doi: 10.1001/jama.2013.282183.

PMID:
24177257
33.

Characterization of salt consumption among hypertensives according to socio-demographic and clinical factors.

Perin MS, Cornélio ME, Rodrigues RC, Gallani MC.

Rev Lat Am Enfermagem. 2013 Sep-Oct;21(5):1013-21. doi: 10.1590/S0104-11692013000500002. English, Portuguese, Spanish.

34.

Effect of implementing an acute myocardial infarction guideline on quality indicators.

Makdisse M, Katz M, Corrêa Ada G, Forlenza LM, Perin MA, de Brito Júnior FS, Nascimento TC, Gomes IM, Franken M, Knobel M, Pesaro AE, dos Santos OF, Cendoroglo Neto M, Lottenberg CL.

Einstein (Sao Paulo). 2013 Jul-Sep;11(3):357-63. English, Portuguese.

35.

Safety and efficacy of biolimus-eluting stent with biodegradable polymer: insights from EINSTEIN (Evaluation of Next-generation drug-eluting STEnt IN patients with coronary artery disease) Registry.

Souza CF, El Mouallem AM, de Brito Júnior FS, Abizaid AA, Almeida BO, Almeida AG, Nascimento TC, Perin MA, Caixeta A.

Einstein (Sao Paulo). 2013 Jul-Sep;11(3):350-6. English, Portuguese.

36.

Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.

Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, Tamburino C, Barbanti M, Chakravarty T, Jilaihawi H, Paradis JM, de Brito FS Jr, Cánovas SJ, Cheema AN, de Jaegere PP, del Valle R, Chiam PT, Moreno R, Pradas G, Ruel M, Salgado-Fernández J, Sarmento-Leite R, Toeg HD, Velianou JL, Zajarias A, Babaliaros V, Cura F, Dager AE, Manoharan G, Lerakis S, Pichard AD, Radhakrishnan S, Perin MA, Dumont E, Larose E, Pasian SG, Nombela-Franco L, Urena M, Tuzcu EM, Leon MB, Amat-Santos IJ, Leipsic J, Rodés-Cabau J.

J Am Coll Cardiol. 2013 Oct 22;62(17):1552-62. doi: 10.1016/j.jacc.2013.07.040. Epub 2013 Aug 14.

37.

3D Echo pilot study of geometric left ventricular changes after acute myocardial infarction.

Vieira ML, Oliveira WA, Cordovil A, Rodrigues AC, Mônaco CG, Afonso T, Lira Filho EB, Perin M, Fischer CH, Morhy SS.

Arq Bras Cardiol. 2013 Jul;101(1):43-51. doi: 10.5935/abc.20130112. Epub 2013 May 31. English, Portuguese.

38.

Clinical, angiographic, and intravascular ultrasound results of the VestSaync II trial.

Costa JR Jr, Oliveira BA, Abizaid A, Costa R, Perin M, Abizaid A, Chamié D, Fernando Tanajura L, Sousa A, Sousa JE.

Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1073-9. doi: 10.1002/ccd.24909. Epub 2014 Aug 22.

PMID:
23460415
39.

Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter study.

Feres F, Costa RA, Bhatt DL, Leon MB, Botelho RV, King SB 3rd, de Paula JE, Mangione JA, Salvadori D Jr, Gusmão MO, Castello H Jr, Nicolela E Jr, Perin MA, Devito FS, Marin-Neto JA, Abizaid A.

Am Heart J. 2012 Dec;164(6):810-6.e3. doi: 10.1016/j.ahj.2012.09.009. Epub 2012 Nov 14.

PMID:
23194480
40.

Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study.

Carraro S, Frigo AC, Perin M, Stefani S, Cardarelli C, Bozzetto S, Baraldi E, Zanconato S.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):793-8.

PMID:
23058033
41.

Immune response to tetanus booster in infants aged 15 months born prematurely with very low birth weight.

Perin MC, Schlindwein CF, de Moraes-Pinto MI, Simão-Gurge RM, de Mello Almada Mimica AF, Goulart AL, dos Santos AM.

Vaccine. 2012 Oct 12;30(46):6521-6. doi: 10.1016/j.vaccine.2012.08.056. Epub 2012 Sep 6.

42.

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial.

Hueb W, Gersh BJ, Rezende PC, Garzillo CL, Lima EG, Vieira RD, Garcia RM, Favarato D, Segre CA, Pereira AC, Soares PR, Ribeiro E, Lemos P, Perin MA, Strunz CC, Dallan LA, Jatene FB, Stolf NA, Hueb AC, Dias R, Gaiotto FA, da Costa LM, Oikawa FT, de Melo RM, Serrano CV Jr, de Ávila LF, Villa AV, Filho JR, Nomura C, Ramires JA, Kalil Filho R; MASS-V Study Group.

BMC Cardiovasc Disord. 2012 Aug 16;12:65. doi: 10.1186/1471-2261-12-65.

43.

Transcatheter bioprosthesis implantation for the treatment of aortic stenosis: three-year experience.

Brito Junior FS, Abizaid A, Almeida BO, Caixeta A, Tarasoutchi F, Grube E, Perin M.

Arq Bras Cardiol. 2012 Aug;99(2):697-705. Epub 2012 Jul 5. English, Portuguese.

44.

Late clinical outcomes after implantation of drug-eluting stents coated with biodegradable polymers: 3-year follow-up of the PAINT randomised trial.

Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE.

EuroIntervention. 2012 May 15;8(1):117-9. doi: 10.4244/EIJV8I1A18.

45.

Evaluation of plaque composition by intravascular ultrasound "virtual histology": the impact of dense calcium on the measurement of necrotic tissue.

Sales FJ, Falcão BA, Falcão JL, Ribeiro EE, Perin MA, Horta PE, Spadaro AG, Ambrose JA, Martinez EE, Furuie SS, Lemos PA.

EuroIntervention. 2010 Aug;6(3):394-9. doi: 10.4244/EIJV6I3A65.

PMID:
20884420
46.

Rationale and design for the PAINT randomized trial.

Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Martinez EE; PAINT study.

Arq Bras Cardiol. 2009 Dec;93(6):547-53, 590-7. English, Portuguese.

47.

Relation between three-dimensional and two-dimensional echocardiography and biochemical analysis in patients with ST-segment elevation myocardial infarction percutaneously treated.

Vieira ML, Oliveira WA, Cury AF, Cordovil A, Rodrigues AC, Naccarato GA, Monaco CG, Costa LP, Romano RB, Calatroia JR, Afonso TR, Tavares GM, Guimarães LA, Lira Filho EB, Perin MA, Fischer CH, Morhy SS.

Einstein (Sao Paulo). 2010 Mar;8(1):53-61. doi: 10.1590/S1679-45082010AO1438. English, Portuguese.

48.

Percutaneous aortic valve replacement for the treatment of aortic stenosis: early experience in Brazil.

Perin MA, Brito FS Jr, Almeida BO, Pereira MA, Abizaid A, Tarasoutchi F, Grube E.

Arq Bras Cardiol. 2009 Sep;93(3):299-306. English, Portuguese, Spanish.

49.

Coronary artery bypass surgery, angioplasty and long term anti-platelet treatment in a type B hemophilia patient.

Pesaro AE, Gaz MV, Karbstein R, Perin M, Serrano CV, Damico E.

Clinics (Sao Paulo). 2009;64(8):822-3. doi: 10.1590/S1807-59322009000800019. No abstract available.

50.

Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.

Lemos PA, Moulin B, Perin MA, Oliveira LA, Arruda JA, Lima VC, Lima AA, Caramori PR, Medeiros CR, Barbosa MR, Brito FS Jr, Ribeiro EE, Martinez EE; PAINT trial investigators.

Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73. doi: 10.1002/ccd.22166.

PMID:
19670303

Supplemental Content

Support Center